Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting - 07/12/23
, Benjamin L. Wright, MD b, c, Dan Atkins, MD d, Seema S. Aceves, MD, PhD e, f, Steven J. Ackerman, PhD g, Amal H. Assa’ad, MD h, Maureen Bauer, MD d, Margaret H. Collins, MD h, Scott P. Commins, MD, PhD i, Carla M. Davis, MD j, k, Evan S. Dellon, MD l, Bethan Doerfler, RDN m, Gerald J. Gleich, MD n, Sandeep K. Gupta, MD, PhD o, David A. Hill, MD, PhD p, q, Elizabeth T. Jensen, PhD r, David Katzka, MD s, Kara Kliewer, PhD h, Ellyn Kodroff t, Leah C. Kottyan, PhD u, Shay Kyle t, Amanda B. Muir, MD p, q, Robert D. Pesek, MD v, w, Kathryn Peterson, MD x, Wayne G. Shreffler, MD, PhD y, z, aa, Jonathan M. Spergel, MD, PhD p, q, Mary Jo Strobel bb, Joshua Wechsler, MD cc, Nives Zimmermann, MD h, Glenn T. Furuta, MD d, Marc E. Rothenberg, MD, PhD hAbstract |
The Consortium of Eosinophilic Gastrointestinal Diseases and The International Gastrointestinal Eosinophil Researchers organized a day-long symposium at the 2022 Annual Meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured a review of recent discoveries in the basic biology and pathogenesis of eosinophilic gastrointestinal diseases (EGIDs) in addition to advances in our understanding of the clinical features of EGIDs. Diagnostic and management approaches were reviewed and debated, and clinical trials of emerging therapies were highlighted. Herein, we briefly summarize the breakthrough discoveries in EGIDs.
Le texte complet de cet article est disponible en PDF.Key words : Eosinophilic esophagitis, eosinophilic gastritis, eosinophil, food allergy
Abbreviations used : CEGIR, EED, EGID, EG-REFS, EoC, EoE, EoEHSS, EoG, EoN, eos/hpf, FDA, OIT, SCIT
Plan
Vol 152 - N° 6
P. 1382-1393 - décembre 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
